pharmaceuticals
US price pressure threatens Switzerland’s pharmaceutical pipeline, industry warns
A new Swiss debate is emerging over the pharmaceutical industry’s future as US pricing pressure threatens the development and availability of new medicines in Switzerland. Industry representatives warn that weaker framework conditions could reduce the sector’s economic contribution and tax revenues.
about 3 hours ago · 1 source
